ebm.bmj

264 A new measure informed decision making in cancer screening: the Amsterdam IDM scale

1 Department of Public and Occupational Health, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands 2 The ...
ebm.bmj

Wrong guidelines: why and how often they occur

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ Evidence-Based Medicine

Methylphenidate denied access to WHO’s list of essential medicines for the third time

Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
ebm.bmj

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...
ebm.bmj

Registration of health and medical research

Registration of health and medical research is an effective way of improving the transparency and credibility of evidence. Registration involves pre-specifying the research objectives, design, methods ...
ebm.bmj

011 Development and nation-wide implementation of a patient decision aid including real-world outcome information to support shared decision making about treatment for non ...

3 Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands 4 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical ...